cover
Article Per Year (5 Year)
All
Home Page
OAI Link
Editorial Team
Contact
Reviewer
Google Scholar
Contact Name
-
Contact Email
-
Phone
-
Journal Mail Official
-
Editorial Address
-
Location
Kota adm. jakarta timur,
Dki jakarta
INDONESIA
Jurnal Respirologi Indonesia
Published by Perhimpunan Dokter Paru Indonesia
ISSN : 08537704     EISSN : 26203162     DOI : -
Core Subject : Health,
Health Professions Medicine & Pharmacology
Jurnal Respirologi Indonesia (JRI) is an online and printed scientific publication of the Indonesian Society of Respirology (ISR). The journal is published thrice-monthly within a year (January, April, July and October). The journal is focused to present original article, article review, and case report in pulmonary and critical care medicine.
Arjuna Subject : -
Articles 10 Documents
 1 
Search results for , issue "Vol 43, No 4 (2023)" : 10 Documents clear
CORRELATIONS BETWEEN MEASUREMENT RV, RV/TLC, FRC/TLC WITH CLINICAL SYMPTOMS IN COPD PATIENTS IN PERSAHABATAN HOSPITALS JAKARTA Derallah Ansusa Lindra; Faisal Yunus; Triya Damayanti
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.571

Abstract

Introduction: This is a preliminary study to measure lung volume in patients with stable COPD in RSUP Persahabatan Jakarta to determine the prevalence of the increasing value of the lung volume in patientswith stable COPD.Methods: This study used a cross-sectional study design of outpatiens with stable COPD who visited Asthma-COPD clinica RSUP Persahabatan Jakarta. The Lung volume test using a gas dilution MBNW taken consecutively from February to March 2016.Results: Test Spirometry and Lung volumes performed on 36 subjects. There were 3 subjects (8.3%) the COPD group A, 10 subjects (27.8%) COPD Group B, 9 subjects (25%) COPD Groups C and 14 subjects (8.9%) COPD Group D. At the age >60 years of 9 there were subjects (25%) and ≥60 years of 27 subjects (75%). Value RV / TLC has a significant relationship with the MmRC scale, a 6-minute walking test and exacerbation within one year, however of FRC / TLC significantly associated with MmRC scale.Conclusion: Value RV / TLC has a significant relationship with the MmRC scale, a 6-minute walking test and exacerbation within one year, however of FRC / TLC significantly associated with MmRC scale.
DIFFERENCES IN C-REACTIVE PROTEIN LEVEL BASED ON CLINICAL SEVERITY AND OUTCOME OF COVID-19 PATIENTS AT RSUP. DR. M. DJAMIL PADANG Isnaniyah Usman; Irvan Medison; Deddy Herman
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.427

Abstract

Background: Inflammatory process in COVID-19 can increase inflammatory markers such as C-reactive protein , procalcitonin , and interleukin. The level of C-reactive protein describes the severity of the viral infection. Several studies have been conducted to investigate the link between C-reactive protein levels and the severity of COVID-19. The purpose of this study is to see if there are any differences in C-reactive protein levels based on clinical degrees and outcomes of COVID-19 patients treated at RSUP by Dr. M. Jamil Padang.Methods: This is a retrospective cohort study with  sample of all COVID-19 patients treated at RSUP by Dr. M. Djamil Padang who met the inclusion and exclusion criteria. The study lasted from December 1, 2021 to June 1, 2022. Data were analyzed using univariate,bivariate and confounding analysis. Results: The characteristics of the patients  were mostly women (51.0%) with range of age 50-59 years (28.0), the most comorbid was hypertension (46.0%). Less than half of the total subjects had secondary infection (49.0%). Most of the subjects had a critical clinical severity (75.0%) and had a length of stay ≤14 days (77.0%) and more than half of the subjects died (65.0%). C-reactive protein levels were higher in patients with critical clinical degrees (89.00 mg/L) compared to moderate (37.50 mg/L) and severe (23.00 mg/L), C-reactive protein levels in patients with long hospitalization ≤ 14 days (97.00 mg/L) was higher than >14 days (88.50 mg/L), and C-reactive protein levels were higher in patients who died (93.00 mg/L) than those who were alive (68.00 mg/L).Conclusion: C-reactive protein levels differed significantly based on clinical severity, length of stay and end of stay status of COVID-19 patients.
THE CORRELATIONS BETWEEN CLINICAL CHARACTERISTICS AND INFLAMMATION MARKERS WITH CHEST X-RAYS IN COVID-19 PATIENTS AT ULIN GENERAL HOSPITAL BANJARMASIN Muhammad Nor; Ira Nurrasyidah; Mashuri Mashuri
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.407

Abstract

Background: Chest x-ray is one of the parameters to estimate the severity and prognosis of COVID-19. Arterial oxygen saturation (SaO2), partial pressure of arterial oxygen (PaO2), and respiratory index (PaO2/FiO2) can also predict the disease severity. Other parameters like inflammation markers also have been used as predictors for prognosis. Based on those considerations, this study will examine their connection and find their correlation. Methods: This is an analytic observational retrospective study design. The samples were moderate-critical COVID-19 patients in Ulin General Hospital Banjarmasin from July - December 2021 who met the inclusion and exclusion criteria. Statistical tests were used to see the relationship between clinical characteristics and inflammation markers with chest X-ray, using various scoring systems (Brixia, sRALE, and modified Soetomo score). Results: Total subjects were 67 patients. The data analysis found that the severity of the disease had a significant relationship with the severity of the chest X-ray (sig. < 0.001). The PF ratio also had a significant negative correlation (sig. < 0.001) with the severity of the chest x-ray. For inflammation markers, NLR, CRP, and LDH significantly correlated with a chest x-ray. The patient's outcome is also associated with a chest X-ray (sig. < 0.015). Conclusion: There were significant correlations between clinical characteristics and inflammation markers on the chest X-ray severity, and sRALE was a better scoring system to assess chest x-ray severity than other scoring systems. Keywords: COVID-19, disease severity, inflammation markers, PF ratio, chest X-ray
Clinical Performance of the Aspergillus Western Blot IgG Kit for Serodiagnosis of Chronic Pulmonary Aspergillosis in Post-Tuberculosis Patients Anna Rozaliyani; Sresta Azahra; Findra Setianingrum; Heri Wibowo
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.562

Abstract

Background: Chronic pulmonary aspergillosis (CPA) due to Aspergillus spp., causing slowly progressive destruction to lung parenchyma, is a major complication of pulmonary tuberculosis (TB). Detecting Aspergillus-specific IgG is critical for diagnosing CPA.Methods: We evaluated the performance of Aspergillus Western Blot (Asp-WB) IgG kit (LDBio Diagnostics, Lyon, France), a commercialized immunoblot assay for the diagnosis of CPA in 63 post-tuberculosis patients.Results: The sensitivity and specificity of Asp-WB were 50% and 93%. There was significant difference of Asp-WB positive results in probable CPA (n = 13) and non-CPA (n = 3) group (50% vs. 8%, p < 0.001). False negative results of Asp-WB were detected from non-fumigatus CPA that grew Aspergillus niger. CPA patients with mild symptoms (less than 3 months) indicated early progression of CPA might showed positive Asp-WB test resultd in low sensitivity of Asp-WB test.Conclusion: This study concluded that Asp-WB has potential to use as confirmatory test to assist diagnosis of CPA in post-TB patients. 
Chest Radiography and CT scan as Predictor Factors for Long Covid Reny Luhur Setyani; Srie Retno Endah; Ana Madjawati; Muhammad Hafiz; Farsida -; Rahma Ayu Larasati; Turwuri Handayani; Khatarina Setyawati
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.539

Abstract

Background: There are several criteria for Long Covid patients and clinicians need to treat and sort out COVID-19 patients based on the risk of worsening, and the severity of lung disease to prevent this condition.Objective: This study is aimed to obtain the relationship between the condition of COVID-19 patients at the time of admission to the hospital based on a chest X-ray using the Brixia Score and the stage on the Chest CT using the Severity Score with symptoms at 6-8 weeks after treatment, which is used as a predictor of the occurrence of Long Covid.Method: The design of this study was a retrospective cohort design to analysis of chest radiography images using the Brixia Score, and the chest CT scan image based on the Severity Score at the time of being diagnosed with COVID-19. The result is then compared with the onset of Long Covid.Result: From 54 research samples, using frequency distribution analysis, the data obtained are 34 non-elderly people (63%) and 20 elderly people (37%); female 26 (48.1%), male 28 (51.9%); 14 people without Long Covid symptoms (25.9%), 40 people with Long Covid symptoms (74.1%); The Brixia Score based on chest radiography obtained 21 mild (38.9%), 20 moderate (37%), 13 severe (24.1%); Severity Score based on CT scan of the thorax found 18 mild (33.3%), 29 moderate (53.7%), 7 severe (13.0%). In the Kolmogorov-Smirnov test, the distribution of data is normal, and in the Pearson test, there is a strong relationship between Brixia Score and Long Covid symptoms (r = 0.553) and the relationship between Severity Score and Long Covid symptoms (r = 0.733) with p = 0.000.Conclusion: There are significant relationships between the Brixia Score and Severity Score with Long Covid symptoms.Keywords: COVID-19, Long Covid, Brixia, Severity Score 
Accuracy of Inhaler Use in COPD Patients and Factors Affecting It Indah Kusumawati Susanti; Rani Sauriasari; Anna Rozaliyani; Dodi Sudiana
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.508

Abstract

Background: Inhaler is a type of dosage form used in the treatment of Chronic Obstructive Pulmonary Disease (COPD). The inhaler has a unique technique for use, however the percentage of accuracy in inhaler use is still low. Whereas proper inhaler use is expected to improve quality of life and decrease the occurrence of exacerbations. Method: This study was conducted with a cross-sectional design on COPD patients in two different hospitals. Primary data were collected using a questionnaire. Accuracy of inhaler use was assessed using a checklist. Results: The total number of patients in this study was 110, with an average age of 62 years. Patients were given single inhaler therapy, which included Dry Powder Inhalers (DPI) for up to 34 patients with 70.7% accuracy, Pressurized Metered-Dose Inhalers (pMDI) for up to 9 persons with 45.74% accuracy, and Soft Mist Inhalers (SMI) for one person with 66.67% accuracy. Furthermore, patients who used a combination of pMDI + DPI inhalers had an accuracy value of 68.53%, and pMDI + SMI had an accuracy value of 72.72%. The stage with the lowest level of accuracy in the pMDI type inhaler used alone was exhaling before the inhaler is supplied. Conclusion:  According to the findings, the accuracy of inhaler use in COPD patients is still relatively low. Furthermore, gender and BMI are factors that have a statistically significant relationship with inhaler accuracy.
THE EFFECT OF INHALED IPRATROPIUM BROMIDE AS A PREMEDICATION FOR BRONCHOSCOPY TO THE BORG SCALE OF DYSPNEA, THE VISUAL ANALOGUE SCALE OF COUGH, AND THE GRADING OF TRACHEOBRONCHIAL SECRETION Safina Mutmainnah; Yusup Subagio Sutanto; Jatu Aphridasari; A. Farih Raharjo
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.256

Abstract

Background: Bronchoscopy is a minimally invasive procedure used for diagnostic examination and intervention of the airways. Patient comfort and cooperation during bronchoscopy is very important because it affects the success and outcome. Sympathetic anticholinergic effect of ipratropium bromide can improve procedure tolerance and airway visualization. The purpose of this study is to analyze the differences of inhaled ipratropium bromide as a bronchoscopy premedication for the assessment of dyspnea, cough, and tracheobronchial secretion.Methods: Clinical study with quasi experimental pretest-post-test control group design in pulmonary patients who underwent bronchoscopy at RSUD Dr. Moewardi Surakarta in October 2021 using consecutive sampling. The subjects of the study were divided into a intervention group with inhaled ipratropium bromide and a control group without inhaled ipratropium bromide. The Borg scale of dyspnea and the visual analogue scale (VAS) score of cough were assessed before and after bronchoscopy in both groups. The grading of tracheobronchial secretions was assessed during bronchoscopy.Results: Thirty-six pulmonary patients who underwent bronchoscopy were included in this study. The intervention group showed less increased in Borg scale (2,00±1,72), VAS score (2,44±1,95), lower of tracheobronchial secretion grading, and there was a significant difference compared to the control (p ≤ 0,005). Thirty-six pulmonary patients who underwent bronchoscopy were included in this study. The intervention group showed less increased in Borg scale (2,00±1,72), VAS score (2,44±1,95), lower of tracheobronchial secretion grading, and there was a significant difference compared to the control (p ≤ 0,005).Conclusion: There was a significant difference on the Borg scale of dyspnea, VAS score of cough, and tracheobronchial secretion grading in patients undergoing bronchoscopy after inhalation of ipratropium bromide.Keywords: inhaled ipratropium bromide, bronchoscopy, Borg scale of dyspnea, VAS score of cough, grading of tracheobronchial secretion  
Bronchoalveolar Lavage (BAL) in Pulmonary Alveolar Proteinosis and Sarcoidosis Prasenohadi Prasenohadi
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.607

Abstract

Bronchoalveolar lavage (BAL) is one of minimal invasive procedure using flexible fiber optic bronchoscopy guidance which safe, easily performed, and well tolerated procedure. Bronchoalveolar lavage procedure is important to diagnose or differential diagnosis patient with clinical appearance and radiological finding not specific. Mechanism related to lung disorder such as inflammation, fibrosis, and abnormal material could be obtained by BAL fluid. Non infection lung disorder such as pulmonary alveolar proteinosis (PAP) and sarcoidosis may be diagnosed by BAL. BAL in non-infection lung disease has diagnostic and therapeutic function. As diagnostic function, BAL could be a tool to obtain lower respiratory tract sample and lavage from respiratory track could be therapeutic function of BAL.Keywords: bronchoalveolar lavage, pulmonary alveolar proteinosis, sarcoidosis.
Education on Inhaler Technique by Pharmacists To Improve The Quality of Life of COPD Patients.: A Systematic Review Sarah Almira; Vincent Pratama; Muh Ronike Yunus; Anna Rozaliyani; Rani Sauriasari
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.479

Abstract

Background: This systematic review aimed to analyze the importance of education on the use of inhalers by pharmacists in improving quality of life, correct inhaler use steps, and medication adherence in patients with Chronic Obstructive Pulmonary Disease (COPD). Methods: The databases used to search for articles in this systematic review include Scopus, ScienceDirect, and Pubmed. The articles submitted were published between 2009 and 2022, with the most recent search being conducted in December 2022. This review included a randomized controlled trial evaluating education on inhaler use techniques by pharmacists in improving the quality of life of COPD patients in inpatient and outpatient settings. This systematic review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) writing guidelines. Results: This systematic review used six articles from five different countries. The articles involved share similar characteristics so that analysis can be carried out. The total number of research subjects included was 913 subjects. Most studies show that there is an increase in the quality of life in COPD patients who are given education on how to use inhalers by pharmacists using print or digital media. Measurements using the St. George's Respiratory Questionnaire (SGRQ) showed a decrease in scores at the 6-month and 12-month periods (-0.75 [95% CI (-1.46 - (-.005)].  Furthermore, two articles reported that education on the technique of using inhalers by pharmacists can also increase the accuracy of using inhalers and three articles reported increasing medication adherence. Conclusion: Interventions such as education on the technique of using inhalers by pharmacists in inpatient and outpatient settings can improve the quality of life of COPD patients, the accuracy of the steps in using inhalers, and medication adherence. 
ANALYSIS OF VOLATILE ORGANIC COMPOUNDS IN EXHALED BREATH OF COVID-19 PATIENTS Tiar Oktavian Effendi; Iin Noor Chozin; Suryanti Dwi Pratiwi; Nanik Setijowati; Arinto Yudi Ponco Wardoyo
Jurnal Respirologi Indonesia Vol 43, No 4 (2023)
Publisher : Perhimpunan Dokter Paru Indonesia (PDPI)/The Indonesian Society of Respirology (ISR)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.36497/jri.v43i4.394

Abstract

Background: More than 2 years since COVID-19’s first cases were reported in 2019. Diagnosis of COVID-19 is a key to controlling the pandemic. Sample for COVID-19 testing is collected by naso-oro-pharyngeal swab. This procedure is often uncomfortable and requires a trained examiner. Exhaled breath contains thousands of volatile organic compounds (VOC) which are likely to change during infection.Aims and objectives: This study aims to analyze the difference of VOC in the exhaled breath between COVID-19 and healthy subjects.Methods: A cross-sectional study carried out recruiting 90 confirmed cases of COVID-19 and 42 healthy subjects. A sample of exhaled breath was collected by using a 500 ml airbag in both groups. Sample was analyzed using an arrayed sensor breath analyzer to quantify the concentration of CO2, C7H8, C6H14, CH2O, NH4, TVOC, NO2, PM1.0, CO, NH3 ­and Acetone. Results: The median of CO2, NH4, TVOC, NO2, and Acetone are significantly lower in COVID-19 patients compared to healthy subjects (respectively 607.3 vs 1175.1; 0.0 vs 1.05; 0.05 vs 146.6; 0.04 vs 1.55; 0.0 vs 0.23) while C7H8, CH2O, CO, and NH3 are significantly higher (respectively 0.92 vs 0.0; 0.55 vs 0.01; 0.24 vs 0.0; 1.99 vs 0.67; all with p-value of <0.05.). Furthermore, we found NH4, Acetone, NH3, and CO are positively correlate with severity of COVID-19, while CO2 and TVOC are negatively correlate. Conclusions: COVID-19 patients emit distinctive VOC profiles in comparison with healthy subjects, and it is related to the severity of the disease.

Page 1 of 1 | Total Record : 10

 1 

Filter by Year

2023 2023


Reset
Filter By Issues
All Issue Vol 43, No 4 (2023) Vol 43, No 3 (2023) Vol 43, No 2 (2023) Vol 43, No 1 (2023) Vol 42, No 4 (2022) Vol 42, No 3 (2022) Vol 42, No 2 (2022) Vol 42, No 1 (2022) Vol 41, No 4 (2021) Vol 41, No 3 (2021) Vol 41, No 2 (2021) Vol 41, No 1 (2021) Vol 40, No 4 (2020) Vol 40, No 3 (2020) Vol 40, No 2 (2020) Vol 40, No 1 (2020) Vol 39, No 4 (2019) Vol 39, No 3 (2019) Vol 39, No 2 (2019) Vol 39, No 2 (2019) Vol 39, No 1 (2019) Vol 39, No 1 (2019) Vol 38, No 4 (2018) Vol 38, No 3 (2018) Vol 38, No 2 (2018) Vol 38, No 1 (2018) Vol 37, No 4 (2017) More Issue